Rottapharm plans debut high yield bond as step towards IPO
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Corporate Bonds

Rottapharm plans debut high yield bond as step towards IPO

Rottapharm Madaus, an Italian-German pharmaceutical company, is looking to raise €400m in its debut bond issue. The planned notes are senior unsecured, have a 2019 maturity and are callable after three years.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article